Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition

ReclutandoFase 3ClinicalTrials.gov

ID: NCT07177352Tipo: INTERVENTIONALInicio: 2 de jul de 2025Fin estimado: 31 de jul de 2035

Traducción no disponible, mostrando original

Resumen

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Elegibilidad

Edad mínima: 50 YearsEdad máxima: 90 YearsSexo: ALL

Criterios de inclusión

\- Report of objective or subjective memory concerns (by the participant and/or their informant) within the last year with or without a previous clinical diagnosis of MCI or dementia due to AD.

Criterios de exclusión

Dependency in basic activities of daily living (bADLs) due to cognitive impairment
Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted)
Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD
History of severe, clinically significant central nervous system trauma
Any serious medical condition that precludes a participant's safe participation and completion of a clinical study

Intervenciones

other

No Intervention

Participants will have their blood drawn and cognitive score measured by the ISLT.

Ubicaciones

INECO Neurociencias Orono

Rosario, Santa Fe Province, Argentina

RECRUITING

Hospital Italiano de Buenos Aires

Buenos Aires, Argentina

RECRUITING

Fundacion Scherbovsky

Mendoza, Argentina

RECRUITING

Sanatorio del Sur S.A.

San Miguel de Tucumán, Argentina

RECRUITING

Patrocinadores

PrincipalHoffmann-La Roche

Contactos

Reference Study ID Number: WP45722 https://forpatients.roche.com/

CONTACT

global-roche-genentech-trials@gene.com 888-662-6728 (U.S. and Canada)

Aviso: La información de este ensayo proviene de fuentes públicas y tiene carácter exclusivamente informativo. No constituye asesoramiento médico, regulatorio ni de ningún otro tipo. Las traducciones son automatizadas y no poseen validez oficial. Consultá siempre con un profesional de la salud. Ver Términos de Uso.

Master Screening Study to Determine Individuals With Pote... | EligiMed